These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8902717)

  • 1. Malignant hyperthermia susceptibility in a patient with concomitant motor neuron disease.
    Monsieurs KG; Van Broeckhoven C; Martin JJ; Dehaene I; Heytens LG
    J Neurol Sci; 1996 Oct; 142(1-2):36-8. PubMed ID: 8902717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes.
    Keating KE; Giblin L; Lynch PJ; Quane KA; Lehane M; Heffron JJ; McCarthy TV
    J Med Genet; 1997 Apr; 34(4):291-6. PubMed ID: 9138151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.
    Moroni I; Gonano EF; Comi GP; Tegazzin V; Prelle A; Bordoni A; Bresolin N; Scarlato G
    J Neurol; 1995 Feb; 242(3):127-33. PubMed ID: 7751854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia.
    Phillips MS; Khanna VK; De Leon S; Frodis W; Britt BA; MacLennan DH
    Hum Mol Genet; 1994 Dec; 3(12):2181-6. PubMed ID: 7881417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
    Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle.
    Richter M; Schleithoff L; Deufel T; Lehmann-Horn F; Herrmann-Frank A
    J Biol Chem; 1997 Feb; 272(8):5256-60. PubMed ID: 9030597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A search for three known RYR1 gene mutations in 41 Swedish families with predisposition to malignant hyperthermia.
    Fagerlund TH; Islander G; Twetman ER; Berg K
    Clin Genet; 1995 Jul; 48(1):12-6. PubMed ID: 7586638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
    Steinfath M; Scholz J; Singh S; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family.
    Steinfath M; Seranski P; Singh S; Fiege M; Wappler F; Schulte Am Esch J; Scholz J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):372-5. PubMed ID: 12237752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation.
    Fletcher JE; Calvo PA; Rosenberg H
    Br J Anaesth; 1993 Sep; 71(3):410-7. PubMed ID: 8398525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype and phenotype relationships for mutations in the ryanodine receptor in patients referred for diagnosis of malignant hyperthermia.
    Fletcher JE; Tripolitis L; Hubert M; Vita GM; Levitt RC; Rosenberg H
    Br J Anaesth; 1995 Sep; 75(3):307-10. PubMed ID: 7547049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the segregation of the RYR1 C184OT mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Hogan K
    Anesthesiology; 1996 Feb; 84(2):29A-30A. PubMed ID: 8602659
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.
    Quane KA; Keating KE; Manning BM; Healy JM; Monsieurs K; Heffron JJ; Lehane M; Heytens L; Krivosic-Horber R; Adnet P
    Hum Mol Genet; 1994 Mar; 3(3):471-6. PubMed ID: 8012359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association between the neuroleptic malignant syndrome and mutations in the RYR1 gene associated malignant hyperthermia.
    Miyatake R; Iwahashi K; Matsushita M; Nakamura K; Suwaki H
    J Neurol Sci; 1996 Nov; 143(1-2):161-5. PubMed ID: 8981316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperthermia--a large kindred linked to the RYR1 gene.
    Wallace AJ; Wooldridge W; Kingston HM; Harrison MJ; Ellis FR; Ford PM
    Anaesthesia; 1996 Jan; 51(1):16-23. PubMed ID: 8669559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.
    Brandt A; Schleithoff L; Jurkat-Rott K; Klingler W; Baur C; Lehmann-Horn F
    Hum Mol Genet; 1999 Oct; 8(11):2055-62. PubMed ID: 10484775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations.
    Fiege M; Wappler F; Weisshorn R; Ulrich Gerbershagen M; Steinfath M; Schulte Am Esch J
    Anesthesiology; 2002 Aug; 97(2):345-50. PubMed ID: 12151923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia.
    O'Brien RO; Taske NL; Hansbro PM; Matthaei KI; Hogan SP; Denborough MA; Foster PS
    J Med Genet; 1995 Nov; 32(11):913-4. PubMed ID: 8592342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of heterozygous and homozygous individuals with the novel RYR1 mutation Cys35Arg in a large kindred.
    Lynch PJ; Krivosic-Horber R; Reyford H; Monnier N; Quane K; Adnet P; Haudecoeur G; Krivosic I; McCarthy T; Lunardi J
    Anesthesiology; 1997 Mar; 86(3):620-6. PubMed ID: 9066328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.